End-stage Renal Disease
Pilot study suggests intranasal theophylline may be worth further investigation as a treatment.
From 2003 to 2011 there was a 26.7% decrease in in-hospital mortality rate after hip fracture.
Gd-IgA1 level may represent a useful biomarker for risk stratification.
HIV-positive individuals with well-controlled disease and no comorbidities have a low risk of ESRD following living kidney donation.
The researchers found that black race and male sex correlated with increased risk of ESRD in donors.
Study demonstrates decreased risk of end-stage renal disease and all-cause mortality.
Action taken to mitigate risks associated with ESA use and changes in payment policy did not result in a relative increase in death or major cardiovascular events.
In-hospital mortality following RFA was higher in older, dialyzed ESRD patients than in non dialyzed patients.
The initiation of RRT has a strong impact on HRQL in comparison with a reference population and with other stages of CKD.
Carriers have a 2-fold higher risk of end-stage renal disease compared with non-carriers, study finds.
Use of bioimpedance spectroscopy to assess volume depletion could be a factor, researchers say.
In a study, 25.8% and 37.8% of calcium acetate and calcium carbonate users, respectively, exceeded the maximum recommended daily intake.
Serum levels of 7 modified metabolites were associated with renal function decline and time to ESRD.
Predictors of renal failure within 10 years include Oxford M1 disease and low eGFR at biopsy.
Non-Hispanic black children had a 36% higher risk of death and Hispanic children had a 34% lower risk of death than non-Hispanic white children.
Since constipation is common, the study findings may be important for public health.
The researchers found that 4.6% of participants developed ESRD and 20.6% died during 30 years of follow-up.
Study finds no increased risk of major adverse cardiovascular events and death.
Every additional absent dorsalis pedis or posterior tibial pulse linked to increased risk of all outcomes.
Increased SBP variability tied to mortality, coronary heart disease, stroke, end-stage renal disease
End-stage renal disease is 32% more likely to develop in patients with C-reactive protein levels of 6.9 mg/L or higher vs 3.0 mg/L or lower.
Screening strategies are needed, as is further research on appropriate therapeutic approach.
More than half of newly diagnosed ESRD patients visit the emergency department during their first year of treatment.
Major fractures included the proximal humerus, forearm, hip, and clinical vertebral fractures.
Data suggest primary GN is more likely than secondary GN to result in end-stage renal disease.
No improvement in kidney failure-free days versus norepinephrine in adults with septic shock.
Highest vs lowest quartile of intake is associated with a 40% increased risk.
A higher allopurinol dose was protective against renal failure in elderly allopurinol recipients.
Researchers find an increased risk of death among patients.
High vs. low fitness levels in midlife lowered CKD risk in later life by 34%.
Renal and Urology News Articles
- For Treating Uremic Pruritus, Evidence is Strongest for Gabapentin
- IgG-Degrading Enzyme Desensitizes, Permits HLA-Incompatible Transplant
- Evaluating Practice Options in the Shifting Health Care Landscape
- Melanoma Risk Higher in Kidney Transplant Recipients
- Kidneys From Octogenarian Donors Show Similar Survival
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)